Changes on the Board of Management and Supervisory Board of Sanochemia Pharmazeutika AG
Sanochemia Pharmazeutika AG announced changes in terms of the management of Sanochemia Pharmazeutika AG for urgent medical reasons pertaining to the former CEO/CFO Herbert Frantsits.
With immediate effect, Werner Frantsits, founder, former CEO and long-standing Chairman of the Supervisory Board, has taken up the position of CEO on an interim basis for the next nine months. The role of Chairman of the Supervisory Board for this period will be assumed by Günter Kahler, long-term General Manager of Forschungsförderungsfonds der Gewerblichen Wirtschaft and for a number of years a member of the Supervisory Board of Sanochemia. After this interim period, Werner Frantsits will reassume the position of Chairman of the Supervisory Board. Until further notice, the area of finances will be overseen by Christoph Stein who has supported the Company as a consultant in this field for the past two years.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.